Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 3, 2010
Regulatory xenobiotic responsive elements in the distal 5'-flanking region of the mouse Cyp1a2 gene required for transcriptional activation by 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxinYuki Kawasaki, Tsutomu Sakuma, Yuma Goto, et al.
Cureus|June 18, 2025
Achieving Complete Response in Metastatic Prostate Cancer With Triplet Therapy and Local Radiation: A Case ReportKatsuki Muramoto, Fumihiko Urabe, Keigo Sakanaka, et al.
Journal of the American Chemical Society|August 27, 2021
Dynamic Polymer Free Volume Monitored by Single-Molecule Spectroscopy of a Dual Fluorescent Flapping DopantYuma Goto, Shun Omagari, Ryuma Sato, et al.
Cureus|May 5, 2025
Complete Response Case of Metastatic Hormone-Sensitive Prostate Cancer Treated With Triplet Therapy (Androgen Deprivation Therapy + Docetaxel + Darolutamide)Tatsuya Shimomura, Fumihiko Urabe, Hajime Onuma, et al.
International Cancer Conference Journal|March 31, 2025
A case of remarkable response to combined radiation therapy, enfortumab vedotin, and pembrolizumab in metastatic urothelial carcinomaFumihiko Urabe, Keigo Sakanaka, Mana Nakata, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2026
Bleeding Events Associated With Continuing Antithrombotic Therapy During Transrectal Ultrasound-Guided Prostate Biopsy: A Propensity Score-Matched AnalysisKenichi Hata, Yuma Goto, Masaki Hashimoto, et al.
Japanese Journal of Clinical Oncology|April 8, 2025
Organ-specific tumor response to enfortumab vedotin in metastatic urothelial carcinoma: a multicenter retrospective studyFumihiko Urabe, Yuki Taneda, Naoki Uchida, et al.
Clinical Genitourinary Cancer|May 10, 2025
Optimal Cystoscopic Surveillance Schedule Following Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaYuhei Koike, Fumihiko Urabe, Katsuki Muramoto, et al.
BJU International|July 19, 2025
Clinical features of medication-related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Yue Ogihara, et al.
Japanese Journal of Clinical Oncology|January 17, 2025
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative studyFumihiko Urabe, Soshi Kadena, Kojiro Tashiro, et al.
Pageof 2